Biography
Dr. Krzysztof Rataj works at the intersection of medicinal chemistry, biology, imaging and artificial intelligence in the field of drug discovery. He obtained a PhD in Biophysics from Jagiellonian University, and worked on numerous projects in collaboration with scientific teams from Hungary, Denmark and Norway. His team explores the application of artificial intelligence approaches to various aspects of drug design and precision medicine, such as transformers for property prediction and compound optimization, natural language processing methods in protein and nucleic acid research, and computer vision in high content screening and histopathology. Their current endeavor is the marriage of chemical structure and phenotypic screening images in order to create a comprehensive approach to high content screening.

AI & Data Science Showcase:
Ardigen
Ardigen is harnessing advanced AI methods for novel precision medicine. The company’s in-house datasets, together with advanced AI platforms, empower the development of effective therapies.

Enhancing Phenotypic Drug Discovery with AI-based Methods
The resurgence of phenotypic screening as a viable method of early drug discovery opens up a new field for application of AI-based methods. We would like to explore the concept of merging high content image data with chemical compound data to provide new quality in HCS pipelines.